Using reverse transcription followed by quantitative PCR (qPCR), we validated the significant downregulation of DRAIR and CPEB2 in CD14+ monocytes from T2D patients versus controls (Figure 2, D and E). The gene discussed is CD14; the disease is type 2 diabetes mellitus.